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Summary The extent of lectin binding by three human melanoma (LOX, FEMX-I and SESX) and two
sarcoma lines (MHMX and OHSX) was related to their potential for experimental metastasis formation in
athymic nude mice. The Helix pomatia agglutinin (HPA), which recognises the N-acetyl-D-galactosamine
ligand, showed differential binding to the cell lines in a manner that correlated with their ability to give lung
colonies after i.v. injection in the mice (P<0.005). The degree of HPA binding and lung colony formation of
the cell lines studied was ranked in the following order, LOX> MHMX>OHSX> SESX> FEMX-I. Similar
patterns were not observed with the other lectins used in this study (WGA, Con A, PNA and UEA-I). The
high HPA reacting LOX melanoma line shows extensive pulmonary metastatic formation with no extrapul-
monary colonies, whereas the low HPA reacting FEMX-I cells give only extrapulmonary metastases with no
detectable colonies in the lungs. Precoating of tumour cells with HPA prior to injection did not reduce the
ability of cells to give pulmonary metastases, suggesting that the HPA epitope was not functionally associated
with the pulmonary metastatic potential observed in nude mice. These findings support recent human studies
of a correlation between HPA binding and incidence of metastasis, however, our data indicate that there is no
causal relationship. Further analyses are required to identify the specific HPA-binding glycoconjugates that
may be involved.
Cancer cells often display aberrant glycosylation of surface
membrane proteins and lipids (Hakomori & Kannagi, 1983;
Reading & Hutchins, 1985). The altered structure or expres-
sion of these sugar-containing molecules on malignant cells is
thought to be important for some of the events leading to the
formation of metastasis (Nicolson, 1984), e.g. for binding the
cells to receptors expressed in endothelium, basal membranes
or extracellular matrices, thereby facilitating the arrest and
extravasation of the tumour cells.
Lectins, because of their binding specificity for carbohy-
drate structures, have been used in many studies to investi-
gate glycoconjugate changes in malignant tissues. Although
their usefulness in these type of studies is limited (Rye et al.,
1993) since t4ey invariably detect a wide range of individual
carbohydrate-containing structures, a number of human
studies have demonstrated altered lectin-binding profiles in
some malignancies. In particular the N-acetyl-D-galactos-
amine-binding lectins (e.g. Helix pomatia agglutinin or HPA)
have been correlated with poor prognosis and metastatic
development in patients with malignant disease of the blad-
der (Nishiyama et al., 1987), breast (Leathem & Brooks,
1987; Springer, 1989; Brooks & Leathem, 1991; Fukutomi et
al., 1991; Schumacher et al., 1992), gastrointestinal tract
(Kakeji et al., 1991) and prostate (Shiraishi et al., 1992).
Most experimental studies on the role of membrane glycon-
jugates in the metastatic process have been performed in
syngeneic rodent tumour systems (Tao & Burger, 1977; Den-
nis et al., 1981; Finne et al., 1989; Hagmar et al., 1990). In
the present study we have used human melanoma and sar-
coma cell lines in nude mice to examine whether a relation-
ship between lectin binding and metastatic potential could be
detected.
Materials and methods
Animals
Congenitally nude mice (Balb/c) were bred and maintained as
previously described (Fodstad et al., 1988a). Animals (4-6
weeks of age) of both sexes were used.
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Tumour cells
Five human tumour cell lines were studied: the LOX (Fod-
stad et al., 1988b), FEMX-I (Fodstad et al., 1988a) and
SESX malignant melanomas, the OHSX osteogenic sarcoma
(Fodstad et al., 1986) and the MHMX unclassified sarcoma.
The cell lines were all established from biopsies of patients at
the Norwegian Radium Hospital. The cells were cultured as
monolayers and as xenografts in nude mice. The monolayer
cultures were maintained at 37°C in RPMI-1640 medium
(Gibco, Paisley, UK) supplemented with 10% fetal calf
serum (Serva, Heidelberg, Germany), 1,000 IU ml-' penicil-
lin, 1I00 lgml-' streptomycin and 2mg I' L-glutamine. The
cells were subcultured twice weekly by detachment with
0.01 M EDTA in calcium- and magnesium-free phosphate-
buffered saline (PBS), and routinely checked with Hoechst
33258 (Sigma, St Louis, MO, USA) staining for Mycoplasma
infection (Chen, 1977). In nude mice, tumours were serially
transplanted either as s.c. xenografts or as ascitic tumours
(FEMX-I). The identity of all cell lines was verified by DNA
fingerprinting.
Experimental metastasisformation
Single-cell suspensions of the MHMX, OHSX and SESX cell
lines were prepared from s.c. xenografts in nude mice as
previously described (Fodstad et al., 1984). FEMX-I cell lines
were obtained from ascitic cultures in nude mice (Fodstad et
al., 1988a). The LOX, OHSX and SESX cell lines were also
obtained from near-confluent monolayer cultures. Previous
studies with LOX, SESX, MHMX and OHSX have shown
that there is no difference in the pattern of metastasis from
cells cultured in vitro or in vivo (unpublished data), but the
FEMX-I cells do not give rise to metastases if grown in
monolayer cultures (Fodstad et al., 1988a).
As estimated by trypan blue exclusion, the cell viability
was always more than 90% for the monolayer cells and more
than 50% for those from xenografts. Nude mice were given
lateral tail vein injections of 1 x 106 (LOX, FEMX-I, SESX,
OHSX) or 2.5-5 x 105 (MHMX) viable cells in 0.2 ml of
RPMI. The animals were checked daily for up to 3 months.
Animals with clear signs of metastatic disease were sacrificed
by a lethal dose ofhalothane/nitrous oxide and the time from
the day of tumour cell injection was recorded.
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Binding oflabelled lectins
The following lectins (Sigma) were used: PNA (Arachis
Hypogaea), Con A (Canavalia ensiformis), WGA (Triticum
vulgaris), HPA (Helix pomatia) and UEA I (Ulex europaeus).
The lectins were labelled with 125I by the lodo-Gen method
(Fraker & Speck, 1978), and separated from free radioiodine
by gel filtration on Sephadex G25 (Pharmacia, Uppsala,
Sweden). The specific activity ranged from 10 to 30gLCi tLg-'
in different preparations. Approximately 10 ng of labelled
lectin was added to 1 x 105 viable EDTA-detached
monolayer cells (MHMX, SESX, LOX and OHSX) or
freshly harvested ascites cells (FEMX-I) suspended in 1 ml of
RPMI medium supplemented with 1 mg ml-' bovine serum
albumin and incubated for 2 h at 4°C. The cells were
pelleted, and after washing three times the cell-associated
radioactivity was determined in a gamma counter. The
amount of cell-associated radiolabelled lectin was expressed
as a percentage of the total radioactivity added.
Pretreatment ofLOX tumour cells with HPA
Since it has previously been shown that HPA has no toxic or
mitogenic effects on cells (Dillner et al., 1975), we were able
to block the HPA binding sites directly with the lectin. LOX
cells were preincubated on ice with HPA (10,gml-') under
serum-free conditions for 1 h. In separate groups of nude
mice, HPA-treated and control cells (5 x 105 cells) were
injected s.c. or i.v. The growth curves of the developing s.c.
tumours were constructed as previously described (Fodstad et
al., 1980), and the development of lung colonies after i.v.
injection was followed by looking for signs of respiratory
distress.
Lectin histochemistry
Histochemistry with peroxidase-labelled lectins was per-
formed as previously described (Rye et al., 1993). In brief,
cytospin preparations of EDTA-detached cells from in vitro
cultures and from ascites tumours in mice (FEMX-I line
only) were fixed in 'dry' acetone for 10 min at room
temperature. Slides were incubated with 10jigml-'
biotinylated lectin for 60 min at room temperature, followed
by detection with streptavidin-biotin-peroxidase (Vectastain
ABC Kit, Vector). Peroxidase was localised using
diaminobenzidine hydrogen peroxide. Parallel sections for
controls were incubated with the appropriate inhibitory sac-
charide.
Statistical analysis
The correlation coefficient (r) was calculated on the extent of
lectin binding in the cell lines and metastases formation. The
significance of the nil correlation was confirmed using the
t-test at three degrees of freedom.
Results
Binding ofradioiodinated lectins to tumour cells
The '251-labelled lectins bound, at saturating concentrations,
to the tumour cell lines, as shown in Table I. With HPA a
100-fold difference was seen in the amount of labelled lectin
bound to the cell line with the highest (LOX) and the lowest
(FEMX-I) binding level. The LOX and the MHMX cells
bound 45% and 25% of the added amount of HPA lectin,
while the value for the OHSX cells was 1.6% and for the
SESX and FEMX-I cells only 0.8% and 0.4% respectively.
The five cell lines bound about equal amounts of WGA,
whereas the binding of Con A differed about 3-fold between
the different cell lines (Table 1). All the lines bound very low
amounts of labelled UEA-I and PNA, with a 4-fold variation
in binding levels.
The amount of labelled lectin bound to the cells (Table I)
correlated well with results obtained from lectin histochemis-
try performed on cells from EDTA-detached in vitro cultures
and from FEMX-I ascites tumours in mice (Figure 1).
Experimental metastasisformation
We have previously reported on the metastasis patterns of
LOX and FEMX-I melanoma cells injected i.v. in nude mice.
The LOX cell line gives lung colonies (Fodstad et al., 1988b),
while the FEMX-I cells give adrenal, subcutaneous and
brown fat metastases (Fodstad et al., 1988a). We have now
investigated the experimental metastasis patterns of three
additional human tumour lines, OHSX, SESX and MHMX,
and the results obtained upon i.v. injections in nude mice are
summarised in Table II, together with the data for LOX and
FEMX-I.
Table I Binding of '251-labelled lectins to human tumour cells
Radiolabelled lectin bound (%)a
Cell line Origin HPA WGA Con A PNA UEA-I
LOX Melanoma 45 30 6.0 0.6 0.5
FEMX-I Melanoma 0.4 32 5.5 0.8 0.5
SESX Melanoma 0.8 33 9.5 0.8 0.9
MHMX Sarcoma 25 33 6.9 1.0 0.6
OHSX Osteosarcoma 1.4 29 3.4 0.7 1.9
aPercentage of total radioactivity added. Values quoted are the mean of three
independent experiments, each performed in triplicate.
Figure 1 Photomicrographs of LOX a, MHMX b, and FEMX-I c, cell lines showing reactivity with peroxidase-labelled Helix
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Table II Experimental metastases formation in nude mice after intravenous injection of cells
from five human tumour cell lines
Cell line Origin Lung colony formation (%)' Extrapulmonary metastasis (%)b
LOX Melanoma 70/70 (100) 0/70 (0)
FEMX-I Melanoma 0/34 (0) 31/34 (94)
SESX Melanoma 2/36 (6) 0/36 (0)
MHMX Sarcoma 24/30 (80) 9/30 (30)
OHSX Osteosarcoma 9/39 (23) 9/39 (23)
aFraction (%) ofinjected animals sacrificed because of symptom-giving lung tumours. bFraction
(%) of injected animals that developed macroscopic tumours outside the lung within an
observation time that differed with the tumour lines (range 30-90 days).
The percentage of animals that developed lung colonies
varied (Table II). The time from day of injection until the
animals had to be sacrificed because of respiratory distress
ranged from 30 days to 90 days in the different cell lines.
With those lines giving extrapulmonary tumours, metastases
were observed in lymph nodes, subcutaneous tissue, heart
and the gastrointestinal tract.
Correlation oflectin binding and experimental metastases
No correlation was found between metastases formation and
the binding of WGA, Con A, PNA and UEA-I (in all cases
P>0.1). However a good correlation was observed between
the binding of HPA lectin and the capacity of the different
cell lines for lung colony formation in nude mice (correlation
coefficient of 0.967, t = 6.58, P<0.005) (Figure 2). The
development of extrapulmonary metastases in mice showed
no relationship to lectin receptor levels in any of the cell lines
tested.
Blocking ofHPA receptors
Given the observed correlation between the HPA-binding
phenotype and lung colony formation in nude mice, the
pretreatment of tumour cells prior to injection was restricted
to the LOX melanoma line: cells preincubated with HPA
immediately before i.v. injection in nude mice showed the
same latency period and organ involvement as control cells.
Thus, the six mice that received 5 x 105 HPA-treated LOX
cells lived for 33.5 ± 6.0 days, and the six control animals for
32.0 ± 5.0 days.
In order to determine that the HPA receptors remained
inaccessible during the course of the experiment, LOX cells
were initially saturated with HPA and subsequently
incubated in vitro for 150 min in serum-containing medium at
37°C in the absence of HPA. The cells did not regain their
ability to bind 125I-labelled HPA (data not shown).
Preincubation of the LOX tumour cells with HPA
(10,ugml-') did not reduce subsequent protein synthesis or
cell proliferation in vitro, and the growth properties of the
treated LOX cells injected s.c. in both flanks of five nude
mice were also unaffected (data not shown).
Discussion
This study has shown that the cellular expression of N-acetyl-
D-galactosamine-containing glycoconjugates as detected by
HPA shows a correlation with pulmonary metastases in
athymic nude mice. It would appear from the results that the
HPA ligand is not directly involved in the formation of
pulmonary metastases. However, one or more of the
glycoconjugates expressing the HPA ligand may conceivably
be involved in this site-specific metastasis.
In other experimental rodent tumour systems correlations
have been observed between the metastatic properties of
tumour cells and their ability to bind different lectins
(Reading et al., 1990; Dennis et al., 1981; Buckley & Carlson,
1988; Finne et al., 1989). Moreover, a similar relationship has
been shown for a human melanoma cell line injected i.v. into
nude mice (Ishikawa & Kerbel, 1989). Lack of correlation
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Figure 2 Correlation of HPA binding and pulmonary metas-
tasis.
between metastatic capacity and N-acetyl-D-galactosamine-
binding lectins (e.g. Glycine max agglutinin or SBA) has
previously been reported for some rodent tumours. Altevogt
et al. (1983) found that low-metastatic cell lines had large
amounts of SBA receptors, and that the inverse was true for
metastatic cells. In other studies (Buckley & Carlsen, 1988), it
was found that the binding of SBA did not correlate with the
appearance of experimental Ixung metastasis, whereas an
apparent association seemed to exist for the formation of
lymph node metastasis. In contrast to the latter observations,
our human FEMX-I cells, which predominantly form lymph
node metastases after i.v. injection into nude mice (Fodstad
et al., 1988a), were found to have small amounts of HPA and
SBA receptors. A lack of correlation with HPA binding has
also been observed in some human studies (Galea et al.,
1991; Taylor et al., 1991). The apparent contradictions and
absence of correlation in some studies may be a result of
quantitative differences in receptor/ligand expression in the
metastatic cell and/or host tissues (Pauli et al., 1990). These
studies also highlight the difficulties of using lectins to iden-
tify individual glycoconjugates associated with specific func-
tions (Rye et al., 1993; Walker, 1993). Our findings with the
other lectins WGA, Con A, PNA and UEA-I support the
cautionary note on the use of lectins in this type of study
(Rye et al., 1993). Nevertheless, HPA binding has identified a
group of N-acetyl-D-galactosamine-containing glycocon-
jugates, one or more of which may be functionally involved
in the site-specific metastatic behaviour that we have
observed in our nude mouse model. The absence of effect on
metastatic or subcutaneous growth when LOX cells were
precoated with HPA indicates that the HPA ligand is not
directly responsible for our observations. However, while we
could not demonstrate any inhibition of effect on metastatic
growth, other factors may have been involved, such as
competitive inhibition by endogenous carbohydrate or lectins
in the murine model. Furthermore, this emphasises the need1024 1. KJ0NNIKSEN et al.
to determine which HPA-binding glycoconjugate(s) are
involved in this metastatic cell behaviour.
The study of metastasis mechanisms involves several in-
herent difficulties. Thus, the end point in vivo is the
appearance of manifest metastatic foci, the development of
which is influenced by a multitude of tumour cell- and host-
associated factors. Injecting the tumour cells by the i.v. route
limits the number of factors involved, but unfortunately it
also reduces the similarity of the models to the situation in
patients. In support of the biological relevance of the distinct
tissue-preferenced growth seen in the present experiments, we
have with LOX and FEMX-I cells observed similar tissue-
preferenced metastasis development also after injection of the
tumour cells either intrasplenic, i.p. or in the footpad of mice
(Fodstad et al., 1988a). In the same study we also showed
that trypsinisation of the LOX cells before i.v. injection
reduces their potential for forming lung colonies in the
recipient animals. That this could have an effect on the HPA
receptor was excluded in the present study, as trypsin treat-
ment of intact cells did not alter the ability of LOX cells to
bind HPA (data not shown).
In spite of the limitations of the experimental metastasis
model used in this study, the data obtained are supported by
studies in other model systems and in humans. Although it is
inappropriate to make generalisations regarding cell charac-
teristics involved in a complex process such as metastasis
formation on the basis of correlations observed in one model
system, our findings do support the recent retrospective
studies in human cancers (Leathem & Brooks, 1987;
Nishiyama et al., 1987; Springer, 1989; Brooks & Leathem,
1991; Fukutomi et al., 1991; Kakeji et al., 1991; Schumacher
et al., 1992; Shiraishi et al., 1992) implicating a role for
HPA-binding glycoconjugates in site-specific metastasis
development.
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